University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Rebecca J. DeBoer, MD, MA

Rebecca J. DeBoer, MD, MA

Fellow in Medical Oncology, UCSF

Cancer Center Program Memberships

Affiliate Member

Research Summary

Rebecca (Becky) DeBoer, MD, MA is a senior fellow in medical oncology at UCSF and a Fogarty GloCal Fellow currently based in Rwanda and Tanzania. She received her BA in Human Biology from Stanford University and her joint MD and MA in Medical Humanities and Bioethics from Northwestern University, and wrote her master’s thesis on The Ethics of Global Cancer Care and Control. She completed residency in internal medicine at the University of Chicago and fellowship at the MacLean Center for Clinical Medical Ethics. During her medical training, she conducted qualitative research on cancer treatment decision-making and research ethics in Mumbai, India, and pursued clinical oncology rotations in Uganda and Nigeria. She then worked as an oncology clinician at the Butaro Cancer Center of Excellence in Rwanda with Partners In Health, where she was engaged in direct patient care, clinical research, and programmatic initiatives.

As a Global Cancer Fellow at UCSF, she is currently leading research on radiotherapy prioritization in the setting of limited resources in Rwanda (supported by a grant from the Greenwall Foundation), clinical decision-making about non-curative cancer treatment in Rwanda and Tanzania (supported by the Fogarty International Center and the National Cancer Institute), and cancer treatment guideline implementation in Tanzania (supported by a Celgene Cancer Care Links grant).


  • Stanford University, B.A., 06/2005, Human Biology
  • Northwestern University Feinberg School of Medicine, M.D., 05/2011, Medicine
  • Northwestern University Program in Medical Humanities and Bioethics, M.A., 03/2014, Medical Humanities and Bioethics
  • University of Chicago, 06/2014, Internal Medicine Residency
  • MacLean Center for Clinical Medical Ethics; Chicago, IL, 06/2016, Clinical Medical Ethics Fellowship
  • University of California, San Francisco, Anticipated 06/2019, Medical Oncology Fellowship

Professional Experience

  • 2005 – 2007
    Clinical Research Coordinator, Division of Neuro-Oncology, UCSF
  • 2011 – 2014
    Internal Medicine Residency, Department of Medicine, University of Chicago
  • 2014 – 2016
    Global Health Hospital Medicine Fellowship, University of Chicago, alternating between: Clinical Associate, Section of Hospital Medicine, University of Chicago AND Oncology Clinical Advisor, Partners In Health/Inshuti Mu Buzima; Butaro Hospital, Rwanda 
  • 2016 – 2018
    ACGME Fellowship in Medical Oncology, Division of Hematology/Oncology, UCSF
  • 2017 – [2019]
    Global Cancer Program Fellowship, Helen Diller Family Comprehensive Cancer Center, UCSF
  • 2017 – [2019]
    Global Health Clinical Scholars Program, UCSF
  • 2018 – [2019]
    Non-ACGME Fellowship in Medical Oncology, Division of Hematology/Oncology, UCSF

Honors & Awards

  • 2003
    Human Biology Research Exploration (HB-REX) Grant (Stanford University)
  • 2004
    Certificate of Special Congressional Recognition for Community Service
  • 2005
    Psi Chi National Honor Society in Psychology
  • 2005
    Albert H. Hastorf Award for Outstanding Service to Program in Human Biology (Stanford University)
  • 2007
    Department of Neurological Surgery Staff Recognition and Development Award (UCSF)
  • 2008
    International Health Fellowship (Northwestern University Feinberg School of Medicine)
  • 2008
    Program in Medical Humanities and Bioethics Travel Grant (Northwestern University)
  • 2008
    Voices Against Brain Cancer (VABC) Young Investigators Research Grant
  • 2014
    19th Congress of the European Hematology Association (EHA) Travel Grant
  • 2017
    Rachel Pearline Award in Recognition of an Extraordinary Commitment to Patient Care (UCSF)

Selected Publications

  1. Xu MJ, Su D, Deboer R, Garcia M, Tahir P, Anderson W, Kinderman A, Braunstein S, Sherertz T. Palliative Oncologic Care Curricula for Providers in Resource-Limited and Underserved Communities: a Systematic Review. J Cancer Educ. 2019 Apr; 34(2):205-215.
    View on PubMed
  2. Rubagumya F, Greenberg L, Manirakiza A, DeBoer R, Park PH, Mpunga T, Shulman LN. Increasing global access to cancer care: models of care with non-oncologists as primary providers. Lancet Oncol. 2017 08; 18(8):1000-1002.
    View on PubMed
  3. Daly B, Hantel A, Wroblewski K, Balachandran JS, Chow S, DeBoer R, Fleming GF, Hahn OM, Kline J, Liu H, Patel BK, Verma A, Witt LJ, Fukui M, Kumar A, Howell MD, Polite BN. No Exit: Identifying Avoidable Terminal Oncology Intensive Care Unit Hospitalizations. J Oncol Pract. 2016 10; 12(10):e901-e911.
    View on PubMed
  4. DeBoer R, Koval G, Mulkey F, Wetzler M, Devine S, Marcucci G, Stone RM, Larson RA, Bloomfield CD, Geyer S, Mullighan CG, Stock W. Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665. Leuk Lymphoma. 2016 10; 57(10):2298-306.
    View on PubMed
  5. Keck MK, Zuo Z, Khattri A, Stricker TP, Brown CD, Imanguli M, Rieke D, Endhardt K, Fang P, Brägelmann J, DeBoer R, El-Dinali M, Aktolga S, Lei Z, Tan P, Rozen SG, Salgia R, Weichselbaum RR, Lingen MW, Story MD, Ang KK, Cohen EE, White KP, Vokes EE, Seiwert TY. Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes. Clin Cancer Res. 2015 Feb 15; 21(4):870-81.
    View on PubMed
  6. Raizer JJ, Fitzner KA, Jacobs DI, Bennett CL, Liebling DB, Luu TH, Trifilio SM, Grimm SA, Fisher MJ, Haleem MS, Ray PS, McKoy JM, DeBoer R, Tulas KM, Deeb M, McKoy JM. Economics of Malignant Gliomas: A Critical Review. J Oncol Pract. 2015 01; 11(1):e59-65.
    View on PubMed
  7. Seiwert TY, Zuo Z, Keck MK, Khattri A, Pedamallu CS, Stricker T, Brown C, Pugh TJ, Stojanov P, Cho J, Lawrence MS, Getz G, Brägelmann J, DeBoer R, Weichselbaum RR, Langerman A, Portugal L, Blair E, Stenson K, Lingen MW, Cohen EE, Vokes EE, White KP, Hammerman PS. Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas. Clin Cancer Res. 2015 Feb 01; 21(3):632-41.
    View on PubMed
  8. Parvataneni R, Polley MY, Freeman T, Lamborn K, Prados M, Butowski N, Liu R, Clarke J, Page M, Rabbitt J, Fedoroff A, Clow E, Hsieh E, Kivett V, Deboer R, Chang S. Identifying the needs of brain tumor patients and their caregivers. J Neurooncol. 2011 Sep; 104(3):737-44.
    View on PubMed
  9. DeBoer R, Batjer H, Marymont M, Goldman S, Walker M, Gottardi-Littell N, Raizer J. Response of an adult patient with pineoblastoma to vorinostat and retinoic acid. J Neurooncol. 2009 Nov; 95(2):289-292.
    View on PubMed
  10. Prados MD, Chang SM, Butowski N, DeBoer R, Parvataneni R, Carliner H, Kabuubi P, Ayers-Ringler J, Rabbitt J, Page M, Fedoroff A, Sneed PK, Berger MS, McDermott MW, Parsa AT, Vandenberg S, James CD, Lamborn KR, Stokoe D, Haas-Kogan DA. Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma. J Clin Oncol. 2009 Feb 01; 27(4):579-84.
    View on PubMed

Go to UCSF Profiles, powered by CTSI